|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
Labels for marking pharmaceutical products, whether self-adhesive or applied with wet glue, have been in existence for as long as labels have. But only in recent years have labels started to be equipped with additional functional features, exceeding the mere purpose of marking products. These features are manifold, being used for such purposes as documentation or the transfer of warnings printed on label parts that can be detached from the identification label. In some cases, several functional features are combined.
All of these solutions primarily aim to provide the ultimate user who will be handling the drug - either to ingest it personally or to administer it to a patient - with time-saving or safety benefits. Documentation mentioned at the beginning of this article, which facilitates the annotation of medical records and other documents with variable data like batch numbers or expiration dates, is one such application.
Equally important is the use of removable parts for marking the container from which a product is ultimately administered to the patient. Lyophilised products, which are dissolved in a solvent, are included as well, just like products in ampoules or vials, which are filled into disposable syringes. In many cases, the drug is not immediately administered to the patient after having been filled into the syringe and, until the drug is ready to be used, the container is left practically unmarked or marked only by crude, makeshift means. Another critical situation arises whenever the individual who has filled the syringe is not the same individual who will be administering the drug to the patient later on.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Clinical Trials in CNS
25-26 November 2008, Copthorne Tara Hotel, London, UK
SMi present their 7th annual conference… Clinical Trials in CNS 25th to 26th November 2008, Copthorne Tara Hotel, London, UK
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
 |
